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Background: The aim of this study was to identify genetic 
variants contributing to preterm birth (PTB) using a linkage 
candidate gene approach.
Methods: We studied 99 single-nucleotide polymorphisms 
(sNPs) for 33 genes in 257 families with PTBs segregating. 
Nonparametric and parametric analyses were used. Premature 
infants and mothers of premature infants were defined as 
affected cases in independent analyses.
results: analyses with the infant as the case identified 
two genes with evidence of linkage: CRHR1 (P = 0.0012) and 
CYP2E1 (P = 0.0011). analyses with the mother as the case iden-
tified four genes with evidence of linkage: ENPP1 (P = 0.003), 
IGFBP3 (P = 0.006), DHCR7 (P = 0.009), and TRAF2 (P = 0.01). 
DNa sequence analysis of the coding exons and splice sites for 
CRHR1 and TRAF2 identified no new likely etiologic variants.
conclusion: These findings suggest the involvement of six 
genes acting through the infant and/or the mother in the etiol-
ogy of PTB.
Preterm birth (PTB) is a major public health issue account-ing for 3 million deaths worldwide each year. Despite a 
slight decrease in the incidence recently, PTB has increased 
from about 10% to more than 12.5% of births over the past two 
decades in the United States (1). Improvements in neonatal 
care have contributed to an increase in survival rates of pre-
term infants (2) in countries with optimal infant health-care 
delivery. However, despite these advances, PTB is still associ-
ated with substantial rates of morbidities, including chronic 
lung disease, patent ductus arteriosus, retinopathy of prema-
turity, intracranial hemorrhage, and cerebral palsy, especially 
in extremely preterm infants (3). These complications, in addi-
tion to PTB itself, are the largest risk factors for infant mortal-
ity in the United States (4).
The majority (72%) of PTBs are spontaneous (5) with 
unknown etiology (6). One substantial risk factor for PTB is 
genetic predisposition (7,8). An infant has an increased risk of 
being premature if the mother was born prematurely (9); if a 
maternal aunt had a premature infant (10); and especially, if the 
mother had a prior PTB (11). Twin studies suggest that the heri-
tability of PTB ranges from 15 to 40% (6). A few other maternal 
risk factors implicated in spontaneous PTB include low socio-
economic status, black race, younger age, intrauterine infection, 
inflammation (6), low prepregnancy weight (12), low choles-
terol levels (13,14), and substance abuse (15,16). Conditions 
such as preeclampsia or fetal distress may lead to induction of 
labor or cesarean delivery before 37 wk gestation, resulting in an 
indicated PTB. Studies have shown that the mother transmits 
much of the genetic risk for spontaneous PTB, with smaller 
contributions from the father and fetus (17–19).
There are a variety of approaches to identifying genes asso-
ciated with a complex trait. A candidate gene approach takes 
advantage of the known biology associated with labor and 
delivery whereas a genome-wide approach can implicate new 
physiologic pathways. In addition to known biology, conserva-
tion of evolutionary mechanisms can also be applied to human 
parturition timing to suggest additional genes (20). There are 
strong arguments for candidate gene studies to continue being 
used in the study of complex disease (21). Linkage studies have 
the ability to detect rare, higher-risk variants and can identify 
causal genes when allelic heterogeneity prevents genome-wide 
association from succeeding (22). We hypothesized that iden-
tification of new genes containing variants contributing to 
familial cases of PTB would be possible using a candidate gene 
linkage approach.
Results
A total of 257 extended families were chosen including 492 pre-
mature infants forming 297 affected-relative pairs (260 infant 
affected pairs and 37 mother affected pairs), see Table 1 for a 
summary by study site. The mean family size for typed mem-
bers was 10.9 ± 3.4 (median = 10; range = 6–27), with a mean of 
2.0 ± 0.9 for typed premature infants (median = 2; range = 1–5) 
and a mean of 1.2 ± 0.4 for typed mothers of premature infants 
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(median = 1; range = 1–3) per pedigree. An initial power anal-
ysis indicated that the sample size for this study was adequate 
to detect evidence of linkage with modest locus heterogeneity 
and Mendelian models. The data for all genes examined for 
either a fetal or maternal effect using nonparametric linkage 
analysis and a transmission disequilibrium test (TDT) are 
summarized in Figures 1 and 2, respectively. The entire data 
set along with parametric linkage results, which did not reveal 
any significant findings, is available in Supplementary Tables 
S1 and S2 online. Two single-nucleotide polymorphisms 
(SNPs)—rs1876831 (CRHR1, P = 5.0 × 10−11) and rs573549 
(APOA1, P = 0.0004)—violated Hardy–Weinberg equilibrium 
and were not included in the analysis.
With the preterm infant as the affected case, a nonparamet-
ric linkage analysis of all candidate genes revealed two linkage 
peaks. These multipoint linkage peaks were on chromosome 
10 (CYP2E1, P = 0.0011–0.002) and chromosome 17 (CRHR1, 
P = 0.0012–0.002). CRHR1 also had significant single-point 
linkage peaks (P = 0.05–0.0014). With the mother of a prema-
ture infant as the affected case, seven linkage peaks were iden-
tified. Four were multipoint linkage peaks on chromosome 6 
(ENPP1, P = 0.003), chromosome 7 (IGFBP3, P = 0.006), chro-
mosome 9 (TRAF2, P = 0.01), and chromosome 11 (DHCR7, 
P = 0.009). Three were single-point linkage peaks on chromo-
some 5 (HAVCR2, rs12654265, P = 0.002), chromosome 10 
(MBL2, rs2136892, P = 0.001), and chromosome 11 (DHCR7, 
rs1790318, P = 0.008).
Using TDT, we identified eight associated SNPs that are 
nominally significant (P < 0.05). However, none fell within the 
most significant linkage peaks based on affection status, and 
none were significant when accounting for multiple compari-
sons using a Bonferroni correction. With the mother as case, 
there was one suggested association with rs10878774 in INFG 
(P = 0.047). With the infant as case, a suggested association 
was seen for rs2303152 in HMGCR (P = 0.046); rs605203 (P = 
0.047), rs7746553 (P = 0.019), and rs592229 (P = 0.034) in C2; 
rs44589901 in DEFA6 (P = 0.036); rs11003136 in MBL2 (P = 
0.003); and rs4760648 in VDR (P = 0.010).
An analysis was performed that stratified premature individu-
als based on type of labor. There were 251 individuals with spon-
taneous, 40 with induced, 36 with no labor (cesarean  section), and 
all others with unknown type of labor. The reason for induction 
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Figure 1. Nonparametric linkage (NPl) single-point (sP) and multipoint (MP) analysis results using either the infant or mother as the affected case are 
graphed by sNP centimorgan position starting with chromosome 1. Diamonds, infant NPl sP results; triangles, infant NPl MP results; squares, mother 
NPl sP results; circles, mother NPl MP results. *P < 0.01. sNP, single-nucleotide polymorphism.
table 1. Number and type of participants by study site
Iowa City, IA (n) Pittsburgh, PA (n) Rochester, NY (n) Wake Forest, NC (n) Denmark (n) total (n)
samples 459 137 64 549 238 1,447
extended families 91 28 13 94 31 257
Affected individuals 173 58 30 168 63 492
Infant affected-relative pairs 79 40 13 89 39 260
 With sibling 61 34 9 72 7 183
 With other relative 18 6 4 17 32 77
Mother affected-relative pairs 4 0 2 8 23 37
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was not known for all individuals in the data set. There was no 
significant difference in mean (P = 0.07) or median (P = 0.19) 
gestational age between those with spontaneous, induced, and 
no labor. When the unknown group was added, a statistically sig-
nificant difference was seen as compared with the no labor group 
(ANOVA mean P = 0.02, median P = 0.01), but no difference was 
seen in comparison with the spontaneous and induced groups. 
Using the preterm infant with spontaneous labor as the affected 
case, a nonparametric linkage analysis revealed two multipoint 
peaks and six single-point peaks. The multipoint peaks were on 
chromosome 9 (TRAF2, P = 0.03) and chromosome 20 (BPI, 
P = 0.03). The single-point peaks were in HMGCR (rs3931914, 
P = 0.04), PTGS1 (rs10513401, P = 0.03), TRAF2 (rs10781522, 
P = 0.04), CRHR1 (rs7225082, P = 0.014), and BPI (rs5743507, 
P = 0.04, and rs4358188, P = 0.04). TDT identified eight sug-
gested  associations: rs7746553 in C2 (P = 0.02), rs4458901 in 
DEFA6 (P = 0.003), rs2515617 in ABCA1 (P = 0.04), rs10781522 
(P = 0.04) and rs4880166 (P = 0.04) in TRAF2, rs11003136 in 
MBL2 (P = 0.02), rs1630498 in DHCR7 (P = 0.01), and rs1893505 
in PGR (P = 0.02).
Linkage haplotype analysis was performed for CRHR1 
because it had the strongest linkage signal. The three SNPs in 
CRHR1 generated seven of a possible eight haplotypes. These 
genotypes were treated as “super alleles” numbered 1 through 
8. Because haplotypes 6 and 7 had low frequencies, they were 
pooled and redefined. Both parametric and nonparametric 
analyses were performed (nonparametric P = 0.0024). The 
dominant model had a log of odds score of 0.82 and heteroge-
neity log of odds score of 1.32 (α = 0.630). The recessive model 
was not significant (log of odds = −18.1, heterogeneity log of 
odds score = 0.329 with α = 0.121). With TDT haplotype asso-
ciation analysis, no individual haplotype was significant (P > 
0.28), with the global P = 0.83.
An initial analysis of 33 SNPs in OXTR, PGR, VDR, CRHR1, 
PTGS1, KCNN3, TRAF2, IGF1R, and NR3C1 was performed 
on a subset of the population (412 premature infants form-
ing 230 affected-relative pairs) in which CRHR1 and TRAF2 
showed evidence of linkage (P = <0.01). Because of strong 
evidence in the literature to support a causal genetic vari-
ant within these genes, we sequenced their coding regions 
rather than the 10–20 centimorgan chromosomal region sur-
rounding the identified linkage peaks. Although previously 
reported SNPs were identified in the coding regions, no novel 
missense, frame-shift, or nonsense mutations were detected.
DIsCussION
Identification of a genetic contribution to PTB would allow 
detection of at-risk pregnancies and might also suggest envi-
ronmental contributors to PTB. This could provide tools 
to prolong gestation by tailoring obstetrical management 
to individual genetic susceptibilities. In the past, interven-
tions for preventing PTB have proven largely unsuccessful 
(23), but by identifying specific individual pathophysiologic 
mechanisms of PTB, new strategies can be developed. In 
this study, we used a linkage candidate gene and sequencing 
approach in an attempt to identify chromosomal regions that 
may contain genes involved in the etiology of PTB. Recently, 
genome-wide association studies have had enormous suc-
cess in identifying genes associated with complex traits, but 
they have not been reported for PTB. In addition, association 
will not identify those genes for which allelic heterogeneity 
is responsible for the heritability even though those alleles 
might have greater impact on the phenotype in a given fam-
ily than common variants typically have. Linkage is the best 
approach to detecting this class of variant. Although previ-
ous studies have supported a stronger maternal contribution 
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Figure 2. transmission disequilibrium test (tDt) analysis results using either the infant or the mother as the affected case are graphed by sNP centimor-
gan position starting with chromosome 1. Diamonds, infant results; squares, mother results. *P < 0.05; **P < 0.01. sNP, single-nucleotide polymorphism.
138 Pediatric ReseaRch     Volume 73  |  Number 2  |  February 2013 copyright © 2013 International Pediatric Research Foundation, Inc.
Articles Bream et al.
to PTB, it is also thought that PTB may be due to the role 
of genes present in the mother/uterus, baby/placenta, or a 
combination of both (8,24). This is the first large linkage 
study focusing on both the mother and the fetus as potential 
risk cases, so the potential linkages identified will be signals 
to be examined in larger studies using more markers and a 
greater number of families than were available in this study. 
Our findings suggest the involvement of CRHR1 or CYP2E1 
mediated by the infant and/or ENPP1, IGFBP3, DHCR7, 
or TRAF2 mediated by the mother in the etiology of PTB. 
CRHR1, DHCR7, and TRAF2, in particular, are members of 
pathways identified in previous studies and have biologic 
plausibility for playing a role in PTB.
CRHR1 encodes one of the two receptors found in humans 
to which corticotropin-releasing hormone (CRH) binds (25). 
CRHR1 is expressed in the pituitary (26), endometrium (27), 
myometrium, and placenta (25), among other locations. The 
coding sequence of CRHR1 is highly conserved, with only six 
missense variants reported in the National Heart, Lung, and 
Blood Institute/Grand Opportunity Exome Sequencing Project 
database (http://evs.gs.washington.edu/EVS/) of over 1,000 
sequenced Europeans. Placental CRH is part of a feed-forward 
loop in both mother and fetus. CRH stimulates the release of 
adrenocorticotropic hormone from the pituitary, which leads 
to the release of glucocorticoids from the adrenal glands, pro-
moting production of more CRH (26,27). Plasma CRH levels 
undergo an exponential increase during pregnancy, peaking at 
the time of delivery (26) due to increased placental produc-
tion and decreased CRH binding protein concentrations (27). 
Women having a PTB undergo a more rapid increase (26), 
establishing different patterns of CRH levels as early as the end 
of the first trimester, suggesting that the length of gestation is 
predetermined and the onset of parturition is triggered when 
CRH levels peak (26). Genetic variants in CRHR1 have also 
been shown to have an association with susceptibility to bacte-
rial vaginosis, which is a risk factor for PTB (28).
7-Dehydrocholesterol reductase catalyzes the final step in 
the synthesis of cholesterol. Cholesterol is an important sub-
strate in the synthesis of many hormones, including placental 
progesterone (13), which is critical for successful reproduction. 
A physiologic hypercholesterolemia has been demonstrated to 
occur later in pregnancy and is thought to be a mechanism for 
pregnancy maintenance (29). A study by Steffen et al. showed 
fetal polymorphisms in DHCR7, as well as other genes involved 
in cholesterol metabolism, to be associated with birth weight 
and PTB. In addition, a strong association was seen between 
low total cholesterol levels during pregnancy in Caucasian 
women and PTB (13).
TRAF2 plays a role in the tumor necrosis factor (TNF) signal 
transduction pathway. In this pathway, TNF binds its receptor 
to recruit caspase 8, initiating apoptosis (30). Activation of this 
pathway via binding to TNF receptor 1 on fetal membranes has 
been implicated in the etiology of premature rupture of mem-
branes (31). TNF also activates the transcription factor nuclear 
factor κB, which interacts with inhibitor-of-apoptosis proteins 
to block caspase 8 (32). TNF binding to TNF receptor 2 on 
fetal membranes activates nuclear factor κB via TNF receptor–
associated factor 2 (TRAF2), leading to increased production of 
inflammatory cytokines. This subsequently increases production 
of prostaglandins, which can initiate preterm labor (31).
There is less evidence to support CYP2E1, ENPP1, and 
IGFBP3 in the etiology of PTB, but they may play a role based 
on known maternal risk factors. Members of the cytochrome 
P450 family are involved in the detoxification and metabolism 
of a variety of substrates as well as synthesis of cholesterol, ste-
roids, and other lipids. CYP2E1, specifically, encodes a protein 
that is induced by ethanol and pathologic states such as fasting, 
diabetes, obesity, and high-fat diet (33). It also metabolizes spe-
cific substrates including ethanol and nitrosamines (34), pre-
mutagens found in cigarette smoke. ENPP1 encodes a protein 
responsible for cleaving pyrophosphate and phosphodiester 
bonds of nucleotides and nucleotide sugars, which are a source 
of chemical energy and play an important role in metabolism. 
Phosphate removal can interrupt the activity of nucleotides, 
resulting in deranged metabolism. IGFBP3 encodes a protein 
that binds the majority of circulating insulin-like growth fac-
tors, which are thought to play a role in fetal and postnatal 
growth (35). Increases in maternal serum levels have been 
associated with increasing gestational age (36), and decreased 
levels have been shown to be present in deliveries before 32 wk 
gestation (35). An increase in inflammatory cytokines has been 
shown to decrease levels of insulin-like growth factor–binding 
protein 3 (IGFBP3) (37), and inflammation is a well-known 
pathway implicated in PTB (6).
For this study, the number of affected-relative pairs was lim-
iting, particularly for mothers of premature infants. Additional 
families could provide power to make a genome-wide linkage 
analysis practical. A second limitation was that roughly one-
third of our cohort had an unknown type of labor. Therefore, 
even though a separate analysis was performed looking at 
spontaneous PTB only, the results should be interpreted 
keeping in mind that the sample size as well as the power of 
the study were both significantly reduced. In addition, there 
were only 40 infants with known induced PTB, and the rea-
son for augmentation was not known for all these infants, 
thereby preventing us from performing a separate analysis of 
these individuals. For future studies, it would be important to 
recruit families for which the type of labor and reasons of aug-
mentation, if applicable, are known in order to have a more 
informative cohort to use for stratified analyses.
Additional sequencing could better characterize the significant 
linkage peaks identified in this study. It would be important to 
look at regulatory elements for CRHR1 and TRAF2 because only 
coding regions were examined. In addition, the coding regions 
and regulatory elements for the other genes with significant 
linkage peaks (CYP2E1, ENPP1, IGFBP3, and DHCR7) should 
be sequenced. An alternative approach would be to saturate the 
chromosomal regions surrounding these genes with additional 
markers and include additional samples for a fine-mapping 
genetic association study with increased power. Whole-exome 
sequencing using familial cases may also provide valuable 
insight. Once we have further defined genetic variants and likely 
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environmental contributors, analyses can be performed to look 
at the interactions and to adjust for confounding variables.
In summary, we have identified several candidate genes/
regions that may harbor rare variants contributing to PTB, 
with one, CRHR1, having the strongest data and in which the 
effect is modulated via the fetus.
MetHODs
DNA Sample Collection
Cases were defined as singleton preterm infants (delivery at <37 
completed weeks of gestation) admitted to one of our centers 
in Iowa City, IA; Pittsburgh, PA; Rochester, NY; Wake Forest, 
NC; or the island of Funen in Denmark. We included both indi-
cated and spontaneous deliveries. Gestational age was estimated 
by the first day of the last menstrual period and confirmed by 
obstetrical examination, including ultrasound when indicated. 
Signed informed consent, approved by the institutional review 
board (no. 199911068) at the University of Iowa, was obtained from 
all families. DNA was extracted from cord blood or buccal swabs 
collected for the infants and venous blood, saliva samples, or buccal 
swabs collected for relatives. Demographic information and addi-
tional phenotype data were collected through an interview with the 
mother and medical chart review.
Family Selection
Families were included if samples were available for a minimum of 
two premature individuals or mothers of premature infants, exclud-
ing multiples, or one premature infant with at least one full-term sib-
ling or cousin. An infant affected-relative pair was defined as any pair 
of premature individuals, excluding infant/parent pairs, within a fam-
ily. A mother affected-relative pair was defined as a pair of sisters both 
having premature infants.
table 2. list of genes and single-nucleotide polymorphisms studied
Gene Chromosome Reference sequence numbers
KCNN3 1 rs10128027 rs1051614 rs11584635 rs12058931
EPHX1 1 rs4559463 rs1051740 rs2740170 rs1009668
CYP1B1 2 rs163076 rs1056836 rs4670813
UGT1A1 2 rs4663333 rs10203852
OXTR 3 rs237887 rs4686301 rs237897
HMGCR 5 rs3931914 rs2303152 rs5908
LNPEP 5 rs4869315 rs3849749 rs4869317 rs13175726
NR3C1 5 rs258747 rs4128753 rs11167814
HAVCR2 5 rs12654265 rs13170556 rs1036199
C2 6 rs605203 rs2734335 rs7746553 rs592229
ENPP1 6 rs943003 rs1409181 rs7754561
IGFBP3 7 rs2453839 rs3110697 rs2132571
DEFA6 8 rs4458901
DEFA4 8 rs2239668
DEFA5 8 rs10095331
ABCA1 9 rs2066716 rs4149313 rs2000069 rs2515617
PTGS1 9 rs10513401 rs5788 rs4240474 rs2778624
TRAF2 9 rs2811761 rs10781522 rs3750512 rs4880166
MBL2 10 rs2136892 rs11003136 rs11003231
CYP2E1 10 rs9418990 rs2070673 rs2249695 rs1536826
DHCR7 11 rs1790318 rs1792325 rs1630498
PGR 11 rs1042839 rs503362 rs1942836 rs1893505
APOA5 11 rs2071522
APOA1 11 rs1729410
VDR 12 rs2239182 rs4760648 rs4516035
INFG 12 rs2098395 rs2069718 rs10878774
IGF1R 15 rs1521480 rs4966036 rs4966038 rs2684811
TP53 17 rs8073498 rs1042522 rs3744262
CRHR1 17 rs7225082 rs4458044 rs173365
BPI 20 rs1341023 rs5743507 rs4358188
CYP24A1 20 rs927650 rs2762941 rs2296241
DACH2     X rs6617219 rs5968924 rs12164321 rs4828153
ZIC3     X rs2859253 rs2746112 rs1085654
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Genotyping
Candidate genes were selected based on biologic plausibility, a review 
of current literature (14,20,26,31,34–36,38–40), and previous asso-
ciation study findings from our lab. The group included 8 genes (BPI, 
C2, DEFA6, DEFA4, DEFA5, INFG, MBL2, and TRAF2) in inflamma-
tory pathways, 12 genes involved in hormonal regulation (ABCA1, 
APOA1, APOA5, CRHR1, CYP1B1, DHCR7, HMGCR, LNPEP, 
NR3C1, OXTR, PGR, and PTGS1), and 13 other genes (CYP24A1, 
CYP2E1, DACH2, ENPP1, EPHX1, HAVCR2, IGF1R, IGFBP3, 
KCNN3, TP53, UGT1A1, VDR, and ZIC3). A list of all 33 genes and 
their respective SNPs—99 of 101 are reported after excluding 2 not in 
Hardy–Weinberg equilibrium—are shown in Table 2.
Genotyping of SNP markers was performed using Applied Biosystems 
(Foster City, CA) TaqMan chemistry. Within each gene, two to four on-
demand SNP genotyping assays were chosen based on linkage disequilib-
rium data available from the International Hapmap project (http://www.
hapmap.org) as well as for their haplotype characteristics, such as high 
heterozygosity and low correlation coefficient, to maximize heterozygos-
ity. The average heterozygosity per locus was 0.85. Applied Biosystems 
provided standard conditions under which the reactions were run. 
Thermocycling was performed with conditions of 95 °C for 10 min fol-
lowed by 50 cycles alternating between 92 °C for 15 s and 60 °C for 1 min. 
Allele determination was done in the end point analysis mode on an 
Applied Biosystems 7900 HT Sequence Detection System machine with 
SDS 2.3 software (Applied Biosystems). Mendelian errors were checked, 
and individuals with >10% error rates were excluded from analyses. 
Genotypes were entered into Progeny (South Bend, IN), a laboratory 
database, and files were generated in linkage format for analysis.
Data Analysis
Two different phenotypic outcomes, premature individuals and moth-
ers of premature individuals, were defined in independent analyses. 
Single-point and multipoint nonparametric and parametric linkage 
analyses, as well as linkage haplotype analysis, were performed using the 
Merlin 1.1.2 software package (http://www.sph.umich.edu/csg/abeca-
sis/Merlin/index.html). Two parametric linkage analysis models, auto-
somal recessive and autosomal dominant, were used assuming a disease 
allele frequency of 0.11 for both. We used penetrances of 0.80, 0.02, and 
0.02 for the recessive model and 0.20, 0.20, and 0.02 for the dominant 
model for the wild-type homozygotes, heterozygotes, and homozygotes, 
respectively. The values selected were based on the rates of PTB in US 
Caucasian populations during the time frame of this study and the pen-
etrances as arbitrary, but midrange, choices based on other complex trait 
models. Changes in penetrances did not greatly affect results.
Association testing was performed on the families with DNA samples 
available to form case–parent triads using the preterm infant or the mother 
of a preterm infant as case. We used the family-based association test 
(http://www.biostat.harvard.edu/~fbat/fbat.htm), a family-based TDT, to 
look for nonrandom allele transmission from parents to offspring.
Sequencing
Primers were designed from public sequence to amplify the cod-
ing regions of CRHR1 and TRAF2 and are available on request. We 
sequenced 190 preterm infants from the linkage cohort and 105 
mothers of preterm infants from a population-matched cohort in 
Helsinki, Finland. In addition, 162 parents of term infants from Iowa 
City, 29 Centre d’Étude du Polymorphisme Humain parents, and 85 
mothers of term infants from Helsinki, Finland, were used as controls. 
PCR products were sent to Functional Biosciences (Madison, WI) for 
sequencing. Chromatograms were transferred to a UNIX worksta-
tion, base called with PHRED (v.0.961028), assembled with PHRAP 
(v. 0.960731), scanned by POLYPHRED (v. 0.970312), and viewed 
with CONSED (v. 4.0) (University of Washington, Seattle, WA).
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